Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.590
+0.620 (63.92%)
May 29, 2025, 3:00 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $280.55 million as of May 30, 2025. Its market cap has decreased by -71.09% in one year.
Market Cap
280.55M
Enterprise Value
144.07M
Revenue
27.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.59
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 280.55M, a decrease of -47.89%. That is a compound annual growth rate of -12.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 29, 2025 | 280.55M | -13.63% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.62B |
Veradigm | 713.27M |
Nika Pharmaceuticals | 667.04M |
Tian'an Technology Group | 614.49M |
Elite Pharmaceuticals | 575.83M |
Glass House Brands | 459.97M |
CytoDyn | 434.59M |
Northwest Biotherapeutics | 388.39M |